Sanofi India Limited (BOM:500674)
India
· Delayed Price · Currency is INR 5,965.35
+33.00 (0.56%)
At close: May 2, 2025
Sanofi India Income Statement
Financials in millions INR. Fiscal year is January - December.
Millions INR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 20,132 | 19,961 | 27,701 | 29,566 | 29,019 | Upgrade
|
| Revenue Growth (YoY) | 0.86% | -27.94% | -6.31% | 1.88% | -5.49% | Upgrade
|
| Cost of Revenue | 9,942 | 9,651 | 12,053 | 13,235 | 12,790 | Upgrade
|
| Gross Profit | 10,190 | 10,310 | 15,648 | 16,331 | 16,229 | Upgrade
|
| Selling, General & Admin | 2,598 | 3,050 | 4,414 | 4,836 | 5,164 | Upgrade
|
| Other Operating Expenses | 2,686 | 2,360 | 4,157 | 3,869 | 3,905 | Upgrade
|
| Operating Expenses | 5,651 | 5,775 | 8,990 | 9,372 | 9,891 | Upgrade
|
| Operating Income | 4,539 | 4,535 | 6,658 | 6,959 | 6,338 | Upgrade
|
| Interest Expense | -15 | -17 | -17 | -18 | -18 | Upgrade
|
| Interest & Investment Income | 132 | 436 | 589 | 631 | 780 | Upgrade
|
| Currency Exchange Gain (Loss) | 22 | 16 | 2 | 5 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 8 | 145 | 122 | 41 | 117 | Upgrade
|
| EBT Excluding Unusual Items | 4,686 | 5,115 | 7,354 | 7,618 | 7,217 | Upgrade
|
| Merger & Restructuring Charges | -377 | -77 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 5 | -21 | -2 | 66 | -28 | Upgrade
|
| Asset Writedown | - | - | -29 | - | - | Upgrade
|
| Other Unusual Items | - | 268 | 1,320 | 4,892 | -417 | Upgrade
|
| Pretax Income | 4,314 | 5,285 | 8,643 | 12,576 | 6,772 | Upgrade
|
| Income Tax Expense | 1,177 | 1,639 | 2,437 | 3,132 | 1,996 | Upgrade
|
| Earnings From Continuing Operations | 3,137 | 3,646 | 6,206 | 9,444 | 4,776 | Upgrade
|
| Earnings From Discontinued Operations | 996 | 2,383 | - | - | - | Upgrade
|
| Net Income | 4,133 | 6,029 | 6,206 | 9,444 | 4,776 | Upgrade
|
| Net Income to Common | 4,133 | 6,029 | 6,206 | 9,444 | 4,776 | Upgrade
|
| Net Income Growth | -31.45% | -2.85% | -34.29% | 97.74% | 15.31% | Upgrade
|
| Shares Outstanding (Basic) | 23 | 23 | 23 | 23 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 23 | 23 | 23 | 23 | 23 | Upgrade
|
| EPS (Basic) | 179.46 | 261.78 | 269.47 | 410.06 | 207.38 | Upgrade
|
| EPS (Diluted) | 179.46 | 261.78 | 269.47 | 410.06 | 207.38 | Upgrade
|
| EPS Growth | -31.45% | -2.85% | -34.29% | 97.74% | 15.31% | Upgrade
|
| Free Cash Flow | 4,251 | 1,961 | 3,765 | 5,358 | 5,697 | Upgrade
|
| Free Cash Flow Per Share | 184.58 | 85.15 | 163.48 | 232.65 | 247.37 | Upgrade
|
| Dividend Per Share | 117.000 | 167.000 | 194.000 | 181.000 | 125.000 | Upgrade
|
| Dividend Growth | -29.94% | -13.92% | 7.18% | 44.80% | 17.93% | Upgrade
|
| Gross Margin | 50.62% | 51.65% | 56.49% | 55.24% | 55.93% | Upgrade
|
| Operating Margin | 22.55% | 22.72% | 24.04% | 23.54% | 21.84% | Upgrade
|
| Profit Margin | 20.53% | 30.20% | 22.40% | 31.94% | 16.46% | Upgrade
|
| Free Cash Flow Margin | 21.12% | 9.82% | 13.59% | 18.12% | 19.63% | Upgrade
|
| EBITDA | 4,852 | 4,847 | 6,984 | 7,537 | 7,091 | Upgrade
|
| EBITDA Margin | 24.10% | 24.28% | 25.21% | 25.49% | 24.44% | Upgrade
|
| D&A For EBITDA | 313 | 312 | 326 | 578 | 753 | Upgrade
|
| EBIT | 4,539 | 4,535 | 6,658 | 6,959 | 6,338 | Upgrade
|
| EBIT Margin | 22.55% | 22.72% | 24.04% | 23.54% | 21.84% | Upgrade
|
| Effective Tax Rate | 27.28% | 31.01% | 28.20% | 24.91% | 29.47% | Upgrade
|
| Revenue as Reported | 20,297 | 20,573 | 28,416 | 30,310 | 29,917 | Upgrade
|
| Advertising Expenses | 179 | 236 | 338 | 461 | 502 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.